The new molecules from the Burris lab could lead to unique treatments for obesity, diabetes, high cholesterol, and sleep disorders.
A team led by Assistant Professor Mansun Law has found antibodies that can prevent infection from widely differing strains of hepatitis C virus in cell culture and animal models.
The study, led by Chair of the Department of Neuroscience Ronald Davis, offers insights into the aging brain.
Associate Professor Timothy Tellinghuisen will lead a three-year study to develop high-throughput screening tests to find compounds that disable a protein essential to hepatitis C virus replication.